We are live on ! Find out more
ETTX

Entasis Therapeutics Holdings Inc.
ETTX

Delisted

ETTX was delisted on the 8th of July, 2022.

Back to rankings

19 hedge funds and large institutions have $54.9M invested in Entasis Therapeutics Holdings Inc. in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

12% more funds holding

Funds holding: 17 → 19 (+2)

5% less capital invested

Capital invested by funds: $57.5M → $54.9M (-$2.64M)

Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$24.3K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$18.7K
3
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$13.7K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$6.43K
5
Wells Fargo
Wells Fargo
California
+$3.21K

Top Sellers

Rank Fund Capital Flow
1
GIM
Granahan Investment Management
Massachusetts
-$38.8K
2
Millennium Management
Millennium Management
New York
-$18.2K
3
UBS Group
UBS Group
Switzerland
-$18.1K
4
PAM
Panagora Asset Management
Massachusetts
-$14.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
NHAS
1
Novo Holdings A/S
Denmark
$14.1M – – –
Blackstone Inc
2
Blackstone Inc
New York
$10.5M – – –
FM
3
Frazier Management
Washington
$8.71M – – –
SI
4
Sofinnova Investments
California
$7.61M – – –
TGHSA
5
TPG Group Holdings (SBS) Advisors
Texas
$6.58M – – –
EAM
6
Eventide Asset Management
Massachusetts
$5.52M – – –
GIM
7
Granahan Investment Management
Massachusetts
$894K -$38.8K -6,042 -4%
Vanguard Group
8
Vanguard Group
Pennsylvania
$317K – – –
Janney Montgomery Scott
9
Janney Montgomery Scott
Pennsylvania
$290K +$13.7K +2,125 +5%
Millennium Management
10
Millennium Management
New York
$183K -$18.2K -2,831 -9%
BlackRock
11
BlackRock
New York
$108K +$24.3K +3,784 +29%
Wells Fargo
12
Wells Fargo
California
$45K +$3.21K +500 +8%
PAM
13
Panagora Asset Management
Massachusetts
$39K -$14.6K -2,276 -28%
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
$19K +$18.7K +2,913 New
OIA
15
OneDigital Investment Advisors
Kansas
$10K +$1.93K +300 +25%
TRCT
16
Tower Research Capital (TRC)
New York
$9K +$2.44K +379 +35%
Bank of Montreal
17
Bank of Montreal
Ontario, Canada
$6K +$6.43K +1,000 New
UBS Group
18
UBS Group
Switzerland
$3K -$18.1K -2,817 -85%
TFS
19
TrustCore Financial Services
Tennessee
$1K – – –

ETTX Hedge Fund Activity: Q2 2019 in Review

19 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Entasis Therapeutics Holdings Inc. (ETTX) for Q2 2019, worth a combined $54.9M — down 4.6% from $57.5M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ETTX positions and 0 closed out — a net gain of 2 holders — while 5 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $24.3K. The largest seller was Granahan Investment Management, cutting an estimated $38.8K.

  • 19 institutional investors held Entasis Therapeutics Holdings Inc. (ETTX) as of Q2 2019, up from 17 in Q1 2019.
  • Funds reported $54.9M of Entasis Therapeutics Holdings Inc. stock for Q2 2019, down 4.6% quarter-over-quarter.
  • 2 funds opened new Entasis Therapeutics Holdings Inc. positions in Q2 2019 and 0 closed out, a net change of +2 holders.
  • The largest Entasis Therapeutics Holdings Inc. buyer in Q2 2019 was BlackRock, an estimated $24.3K added.
  • The largest Entasis Therapeutics Holdings Inc. seller in Q2 2019 was Granahan Investment Management, an estimated $38.8K sold.

Based on aggregated 13F filings for Q2 2019.